Vest Financial LLC Invests $1.47 Million in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Vest Financial LLC acquired a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 17,520 shares of the medical instruments supplier's stock, valued at approximately $1,470,000. Vest Financial LLC owned 0.08% of LeMaitre Vascular as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the business. NBC Securities Inc. acquired a new position in shares of LeMaitre Vascular during the 1st quarter valued at about $36,000. Smartleaf Asset Management LLC grew its holdings in LeMaitre Vascular by 234.4% in the fourth quarter. Smartleaf Asset Management LLC now owns 418 shares of the medical instruments supplier's stock valued at $39,000 after purchasing an additional 293 shares during the period. CBIZ Investment Advisory Services LLC increased its position in LeMaitre Vascular by 38.5% during the fourth quarter. CBIZ Investment Advisory Services LLC now owns 421 shares of the medical instruments supplier's stock worth $39,000 after purchasing an additional 117 shares during the last quarter. KBC Group NV increased its position in LeMaitre Vascular by 58.4% during the fourth quarter. KBC Group NV now owns 1,112 shares of the medical instruments supplier's stock worth $102,000 after purchasing an additional 410 shares during the last quarter. Finally, Huntington National Bank raised its stake in LeMaitre Vascular by 64.9% during the fourth quarter. Huntington National Bank now owns 1,156 shares of the medical instruments supplier's stock worth $107,000 after purchasing an additional 455 shares during the period. 84.64% of the stock is currently owned by institutional investors and hedge funds.

LeMaitre Vascular Stock Down 1.0%

Shares of NASDAQ LMAT traded down $0.81 on Monday, hitting $83.32. The company had a trading volume of 97,071 shares, compared to its average volume of 168,453. LeMaitre Vascular, Inc. has a 12-month low of $71.42 and a 12-month high of $109.58. The firm has a market capitalization of $1.88 billion, a P/E ratio of 45.53, a PEG ratio of 2.22 and a beta of 0.83. The business has a 50 day moving average of $83.65 and a two-hundred day moving average of $90.74.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share for the quarter, missing analysts' consensus estimates of $0.50 by ($0.02). The company had revenue of $59.87 million during the quarter, compared to analysts' expectations of $57.61 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The firm's revenue was up 12.0% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.44 EPS. On average, sell-side analysts anticipate that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, May 29th. Shareholders of record on Thursday, May 15th were issued a $0.20 dividend. The ex-dividend date was Thursday, May 15th. This represents a $0.80 dividend on an annualized basis and a yield of 0.96%. LeMaitre Vascular's dividend payout ratio is currently 40.40%.

Insider Buying and Selling at LeMaitre Vascular

In other LeMaitre Vascular news, CEO George W. Lemaitre sold 18,733 shares of the firm's stock in a transaction on Friday, May 16th. The shares were sold at an average price of $84.77, for a total transaction of $1,587,996.41. Following the completion of the transaction, the chief executive officer now directly owns 1,873,651 shares of the company's stock, valued at $158,829,395.27. This trade represents a 0.99% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Trent G. Kamke sold 2,009 shares of LeMaitre Vascular stock in a transaction that occurred on Wednesday, March 12th. The stock was sold at an average price of $82.12, for a total value of $164,979.08. Following the completion of the transaction, the insider now owns 5,564 shares of the company's stock, valued at approximately $456,915.68. The trade was a 26.53% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 102,009 shares of company stock valued at $8,721,836 in the last ninety days. Insiders own 9.50% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently commented on LMAT shares. Oppenheimer downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Wells Fargo & Company began coverage on LeMaitre Vascular in a research report on Thursday, February 13th. They set an "equal weight" rating and a $95.00 price target for the company. Barrington Research downgraded LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a report on Friday, February 28th. Finally, Lake Street Capital boosted their target price on LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a report on Friday, February 28th. Five research analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of "Hold" and an average target price of $97.83.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.